Drug Shortage Report for MAXALT RPD

Last updated on 2021-09-30 History
Report ID 145497
Drug Identification Number 02240518
Brand name MAXALT RPD
Common or Proper name rizatriptan benzoate wafers
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 12
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-09-17
Actual start date 2021-09-16
Estimated end date 2021-09-29
Actual end date 2021-09-29
Shortage status Resolved
Updated date 2021-09-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-09-10 English Compare
v2 2021-09-10 French Compare
v3 2021-09-16 English Compare
v4 2021-09-16 French Compare
v5 2021-09-17 English Compare
v6 2021-09-21 English Compare
v7 2021-09-23 English Compare
v8 2021-09-29 English Compare
v9 2021-09-29 French Compare
v10 2021-09-30 English Compare

Showing 1 to 10 of 10